This content is from: Premium

Juul’s Hedge Fund Investors Avoid Disaster

Despite the huge valuation hit taken by the e-cigarette maker, most funds that invested early have avoided the pain suffered by Altria.

Talk about a spectacular fall from grace.The Food and Drug Administration’s stunning order that Juul Labs must remove its vaping products from the U.S. market all but ends the meteoric rise and colossal collapse of a company that once attracted several high-profile hedge fund investors and was once the third

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content